International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia
Authors
Keywords
Quality of life, Symptoms, Hodgkin lymphoma, Non-Hodgkin lymphoma, Chronic lymphocytic leukaemia
Journal
QUALITY OF LIFE RESEARCH
Volume 27, Issue 2, Pages 333-345
Publisher
Springer Nature
Online
2017-11-10
DOI
10.1007/s11136-017-1718-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted therapies for CLL: Practical issues with the changing treatment paradigm
- (2016) Nitin Jain et al. BLOOD REVIEWS
- Changes in the survival of older patients with hematologic malignancies in the early 21st century
- (2016) Dianne Pulte et al. CANCER
- Focusing on Core Patient-Reported Outcomes in Cancer Clinical Trials—Letter
- (2016) Mogens Groenvold et al. CLINICAL CANCER RESEARCH
- Health-related quality of life in Hodgkin lymphoma: a systematic review
- (2016) Nadine Linendoll et al. Health and Quality of Life Outcomes
- Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial
- (2016) Laurie H Sehn et al. LANCET ONCOLOGY
- Initial therapy of chronic lymphocytic leukemia
- (2016) Barbara Eichhorst et al. SEMINARS IN ONCOLOGY
- Cost-effectiveness of rituximab in addition to fludarabine and cyclophosphamide (R-FC) for the first-line treatment of chronic lymphocytic leukemia
- (2015) Dirk Müller et al. LEUKEMIA & LYMPHOMA
- Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: comparison between European population-based data (EUROCARE-5)
- (2015) Morgane Mounier et al. Lancet Haematology
- Health-related quality of life and persistent symptoms in relation to (R-)CHOP14, (R-)CHOP21, and other therapies among patients with diffuse large B-cell lymphoma: results of the population-based PHAROS-registry
- (2014) Simone Oerlemans et al. ANNALS OF HEMATOLOGY
- Impact of therapy and disease-related symptoms on health-related quality of life in patients with follicular lymphoma: results of the population-based PHAROS-registry
- (2014) Simone Oerlemans et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women: a Swedish Lymphoma Registry Study
- (2014) H R Junlén et al. LEUKEMIA
- Quality of life more impaired in younger than in older diffuse large B cell lymphoma survivors compared to a normative population: a study from the population-based PROFILES registry
- (2013) M. W. M. van der Poel et al. ANNALS OF HEMATOLOGY
- Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma
- (2013) E. Bachy et al. HAEMATOLOGICA
- Adult survivors of childhood malignant lymphoma are not aware of their risk of late effects
- (2011) Siri L. Hess et al. ACTA ONCOLOGICA
- The impact of treatment, socio-demographic and clinical characteristics on health-related quality of life among Hodgkin’s and non-Hodgkin’s lymphoma survivors: a systematic review
- (2011) Simone Oerlemans et al. ANNALS OF HEMATOLOGY
- Diverging trends in incidence and mortality, and improved survival of non-Hodgkin's lymphoma, in the Netherlands, 1989-2007
- (2011) S. A. M. van de Schans et al. ANNALS OF ONCOLOGY
- A population-based study of follow-up care for Hodgkin lymphoma survivors
- (2010) David C. Hodgson et al. CANCER
- Late Effects of Hodgkin’s Disease and Its Treatment
- (2010) Andrea K. Ng et al. CANCER JOURNAL
- Chronic Lymphocytic Leukemia: New Concepts for Future Therapy
- (2010) William G. Wierda et al. Clinical Lymphoma Myeloma & Leukemia
- Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
- (2010) M Hallek et al. LANCET
- Hodgkin Lymphoma Across the Age Spectrum: Epidemiology, Therapy, and Late Effects
- (2009) Angela Punnett et al. SEMINARS IN RADIATION ONCOLOGY
- Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
- (2008) F. Rodeghiero et al. BLOOD
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines
- (2008) M. Hallek et al. BLOOD
- Health-related quality of life assessment and reported outcomes in leukaemia randomised controlled trials – A systematic review to evaluate the added value in supporting clinical decision making
- (2008) Fabio Efficace et al. EUROPEAN JOURNAL OF CANCER
- Hodgkin Lymphoma: The Follow-Up of Long-Term Survivors
- (2008) David C. Hodgson HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Phase III Study of R-CVP Compared With Cyclophosphamide, Vincristine, and Prednisone Alone in Patients With Previously Untreated Advanced Follicular Lymphoma
- (2008) Robert Marcus et al. JOURNAL OF CLINICAL ONCOLOGY
- Adult life after surviving lymphoma in childhood
- (2008) Nicolas X. von der Weid SUPPORTIVE CARE IN CANCER
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started